261 related articles for article (PubMed ID: 28895843)
1. Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy.
Kohn DB
Hematol Oncol Clin North Am; 2017 Oct; 31(5):721-735. PubMed ID: 28895843
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy for β-Hemoglobinopathies.
Cavazzana M; Antoniani C; Miccio A
Mol Ther; 2017 May; 25(5):1142-1154. PubMed ID: 28377044
[TBL] [Abstract][Full Text] [Related]
3. Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis.
Biasco L; Rothe M; Schott JW; Schambach A
Hematol Oncol Clin North Am; 2017 Oct; 31(5):737-752. PubMed ID: 28895844
[TBL] [Abstract][Full Text] [Related]
4. Treating Immunodeficiency through HSC Gene Therapy.
Booth C; Gaspar HB; Thrasher AJ
Trends Mol Med; 2016 Apr; 22(4):317-327. PubMed ID: 26993219
[TBL] [Abstract][Full Text] [Related]
5. Evolving Gene Therapy in Primary Immunodeficiency.
Thrasher AJ; Williams DA
Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy for Hemoglobinopathies.
Cavazzana M; Mavilio F
Hum Gene Ther; 2018 Oct; 29(10):1106-1113. PubMed ID: 30200783
[TBL] [Abstract][Full Text] [Related]
7. Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells.
Rivière J; Hauer J; Poirot L; Brochet J; Souque P; Mollier K; Gouble A; Charneau P; Fischer A; Pâques F; de Villartay JP; Cavazzana M
Gene Ther; 2014 May; 21(5):529-32. PubMed ID: 24622732
[TBL] [Abstract][Full Text] [Related]
8. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
9. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
Rethwilm A
Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
[TBL] [Abstract][Full Text] [Related]
10. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy Approaches to Hemoglobinopathies.
Ferrari G; Cavazzana M; Mavilio F
Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
[TBL] [Abstract][Full Text] [Related]
12. Retrovirus and lentivirus vector design and methods of cell conditioning.
Cooray S; Howe SJ; Thrasher AJ
Methods Enzymol; 2012; 507():29-57. PubMed ID: 22365768
[TBL] [Abstract][Full Text] [Related]
13. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
Cavazzana M; Six E; Lagresle-Peyrou C; André-Schmutz I; Hacein-Bey-Abina S
Hum Gene Ther; 2016 Feb; 27(2):108-16. PubMed ID: 26790362
[TBL] [Abstract][Full Text] [Related]
15. Gene Editing: Regulatory and Translation to Clinic.
Ando D; Meyer K
Hematol Oncol Clin North Am; 2017 Oct; 31(5):797-808. PubMed ID: 28895848
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.
Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB
Stem Cells; 2015 May; 33(5):1532-42. PubMed ID: 25588820
[TBL] [Abstract][Full Text] [Related]
17. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
Suerth JD; Maetzig T; Brugman MH; Heinz N; Appelt JU; Kaufmann KB; Schmidt M; Grez M; Modlich U; Baum C; Schambach A
Mol Ther; 2012 May; 20(5):1022-32. PubMed ID: 22334016
[TBL] [Abstract][Full Text] [Related]
18. Role of the mammalian target of rapamycin pathway in lentiviral vector transduction of hematopoietic stem cells.
Wang CX; Torbett BE
Curr Opin Hematol; 2015 Jul; 22(4):302-8. PubMed ID: 26049750
[TBL] [Abstract][Full Text] [Related]
19. Overview of the current status of gene therapy for primary immune deficiencies (PIDs).
Kuo CY; Kohn DB
J Allergy Clin Immunol; 2020 Aug; 146(2):229-233. PubMed ID: 32771134
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Gene Therapy, Historical Perspective.
Malech HL; Garabedian EK; Hsieh MM
Hematol Oncol Clin North Am; 2022 Aug; 36(4):627-645. PubMed ID: 35773053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
